Sydney, June 11, 2026, 16:10 AEST
- ALS ended down again, closing at A$22.28 for its second loss in a row.
- The shares go ex-dividend June 12 for a final dividend of 23.1¢.
- ALS will be added to the S&P/ASX 50, effective before the open on June 22.
ALS Ltd (ASX: ALQ) shares lost 2.02% to finish at A$22.28 on Thursday, adding to a 3.44% decline the day before. The lab testing company started the week at A$23.55. ALS shares moved between A$22.04 and A$22.71 through the session. Trading volume came in around 2.60 million shares, Investing.com data showed.
ALS underperformed the wider Australian market. The S&P/ASX 200 finished June 11 down 0.23% at 8,633.20, moving between 8,555.30 and 8,670.20 in the session. ALS’s fall was steeper than the index’s drop.
Not much news from companies this week. ALS’s investor page is showing the June 5 S&P DJI rebalance notice as the latest ASX update. S&P Dow Jones Indices is adding ALS to the S&P/ASX 50 Index, replacing Pro Medicus, ahead of the open on June 22, according to the notice.
Next up on the calendar for ALS is its final dividend. ALS’s latest dividend table puts the final dividend at 23.1¢, franked at 30%. The ex-dividend date lands on June 12, with July 3 set for payment. ALS’s own calendar has the record date as June 15 and repeats July 3 for payment. Intelligent Investor
ALS set its final dividend at 23.1¢ per share after posting a record FY26 result in May. Full-year DPS came to 42.5¢. The company reported revenue of A$3.32 billion, up 10.7%. Underlying EBIT was A$599.0 million, up 19.3%. Underlying NPAT rose 25.8% to A$381.2 million. CEO and Managing Director Malcolm Deane said ALS had “robust financial performance in FY26,” citing portfolio resilience and disciplined execution. ALS Global ALS Global
ALQ’s earnings mix is still in focus for investors watching the stock. ALS said its Commodities arm got a boost from ongoing strength in mineral exploration. Higher sample volumes and improved pricing drove up Minerals margins. In Life Sciences, Food performed, but weaker Environmental and Pharmaceutical demand weighed. ALS Global
ALS is trading at A$22.28, holding above the 52-week low at A$16.45 and under the high of A$26.17. The stock’s near-term moves are expected to reflect Friday’s ex-dividend date and how investors set up ahead of the ASX 50 rebalancing on June 22, not the latest earnings numbers.
